| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Bicara Therapeutics Inc. (BCAX) have been net sellers, shedding 58,750 shares worth roughly $1.6M on balance.
BCAX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.60M | $73.65M | - | |
| CEO | 362.2K | $10.13M | - | |
| CEO | 181.6K | $4.26M | - | |
| CFO | 129.9K | $492.1K | - | |
| Other | 55.3K | $1.26M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | Raben David49 | Chief Medical Officer | Sale+OE10b5-1 | 5,500 | $22.88 | $125,830.10 | -9.0% | +23.7% | - | |
| Apr 21, 2026 | Hyep Ivan62 | Chief Financial Officer | Sale+OE10b5-1 | 9,200 | $23.00 | $211,613.80 | -6.0% | +17.5% | - | |
| Apr 20, 2026 | Mazumdar Claire52 | Chief Executive Officer | Sale+OE10b5-1 | 15,000 | $23.61 | $354,145.50 | -4.0% | +15.7% | - | |
| Apr 15, 2026 | Cohlhepp Ryan52 | President and COO | Sale+OE10b5-1 | 12,500 | $23.01 | $287,591.25 | -6.0% | +18.5% | - | |
| Mar 25, 2026 | Raben David49 | Chief Medical Officer | Sale+OE10b5-1 | 5,500 | $18.95 | $104,229.40 | -9.0% | +33.8% | - | |
| Mar 23, 2026 | Hyep Ivan62 | Chief Financial Officer | Sale+OE10b5-1 | 9,200 | $18.52 | $170,348.12 | -6.0% | +33.5% | - | |
| Mar 20, 2026 | Mazumdar Claire52 | Chief Executive Officer | Sale+OE10b5-1 | 15,000 | $18.82 | $282,365.69 | -4.2% | +26.2% | - | |
| Mar 16, 2026 | Cohlhepp Ryan52 | President and COO | Sale+OE10b5-1 | 12,500 | $19.66 | $245,713.75 | -5.9% | +11.1% | - | |
| Mar 9, 2026 | Mazumdar Claire52 | Chief Executive Officer | Sale+OE10b5-1 | 36,766 | $19.17 | $704,657.16 | -9.8% | +2.1% | - | |
| Mar 6, 2026 | Mazumdar Claire52 | Chief Executive Officer | Sale+OE10b5-1 | 8,234 | $18.74 | $154,324.53 | -2.4% | +10.7% | - |